Exelixis Earnings Estimate

EXEL Stock  USD 46.51  0.10  0.21%   
The next projected EPS of Exelixis is estimated to be 0.695 with future projections ranging from a low of 0.59 to a high of 0.82. Exelixis' most recent 12-month trailing earnings per share (EPS TTM) is at 2.38. Please be aware that the consensus of earnings estimates for Exelixis is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Exelixis is projected to generate 0.695 in earnings per share on the 31st of March 2026. Exelixis earnings estimates show analyst consensus about projected Exelixis EPS (Earning Per Share). It derives the highest and the lowest estimates based on Exelixis' historical volatility. Many public companies, such as Exelixis, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Exelixis Revenue Breakdown by Earning Segment

By analyzing Exelixis' earnings estimates, investors can diagnose different trends across Exelixis' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is expected to rise to about 2.2 B this year, although the value of Pretax Profit Margin will most likely fall to 0.14. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in consumer price index.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Exelixis Earnings Estimation Breakdown

The calculation of Exelixis' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Exelixis is estimated to be 0.695 with the future projection ranging from a low of 0.59 to a high of 0.82. Please be aware that this consensus of annual earnings estimates for Exelixis is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.59
Lowest
Expected EPS
0.695
0.82
Highest

Exelixis Earnings Projection Consensus

Suppose the current estimates of Exelixis' value are higher than the current market price of the Exelixis stock. In this case, investors may conclude that Exelixis is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Exelixis' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
2075.52%
0.0
0.695
2.38

Exelixis Earnings History

Earnings estimate consensus by Exelixis analysts from Wall Street is used by the market to judge Exelixis' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Exelixis' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Exelixis Quarterly Gross Profit

579.18 Million

At this time, Exelixis' Price Earnings Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 2.62 this year, although the value of Retained Earnings will most likely fall to (103.6 M). Net Income Applicable To Common Shares is expected to rise to about 220.1 M this year, although the value of Common Stock Shares Outstanding will most likely fall to about 184.2 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Exelixis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
44.0446.6549.26
Details
Intrinsic
Valuation
LowRealHigh
44.8747.4850.09
Details
Naive
Forecast
LowNextHigh
46.5749.1851.79
Details
20 Analysts
Consensus
LowTargetHigh
41.2045.2850.26
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Exelixis assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Exelixis. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Exelixis' stock price in the short term.

Exelixis Earnings per Share Projection vs Actual

Actual Earning per Share of Exelixis refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Exelixis predict the company's earnings will be in the future. The higher the earnings per share of Exelixis, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Exelixis Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Exelixis, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Exelixis should always be considered in relation to other companies to make a more educated investment decision.

Exelixis Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Exelixis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2025-10-27
2025-09-300.69310.780.086912 
2025-07-28
2025-06-300.640.650.01
2025-04-28
2025-03-310.36660.620.253469 
2025-02-04
2024-12-310.49180.550.058211 
2024-10-29
2024-09-300.350.40.0514 
2024-08-06
2024-06-300.30.770.47156 
2024-04-30
2024-03-310.240.2-0.0416 
2024-02-06
2023-12-310.210.270.0628 
2023-11-01
2023-09-300.10.10.0
2023-08-01
2023-06-300.160.250.0956 
2023-05-09
2023-03-310.150.12-0.0320 
2023-02-07
2022-12-31-0.12-0.090.0325 
2022-11-01
2022-09-300.190.230.0421 
2022-08-09
2022-06-300.190.220.0315 
2022-05-10
2022-03-310.140.210.0750 
2022-02-17
2021-12-310.060.290.23383 
2021-11-02
2021-09-300.170.12-0.0529 
2021-08-05
2021-06-300.060.30.24400 
2021-05-06
2021-03-310.030.005-0.02583 
2021-02-10
2020-12-310.050.090.0480 
2020-11-05
2020-09-300.01-0.1-0.111100 
2020-08-06
2020-06-300.120.210.0975 
2020-05-05
2020-03-310.130.150.0215 
2020-02-25
2019-12-310.170.220.0529 
2019-10-30
2019-09-300.190.310.1263 
2019-07-31
2019-06-300.230.250.02
2019-05-01
2019-03-310.230.240.01
2019-02-12
2018-12-310.230.370.1460 
2018-11-01
2018-09-300.190.410.22115 
2018-08-01
2018-06-300.160.280.1275 
2018-05-02
2018-03-310.160.370.21131 
2018-02-26
2017-12-310.120.120.0
2017-11-01
2017-09-300.080.260.18225 
2017-08-02
2017-06-300.040.060.0250 
2017-05-01
2017-03-31-0.010.050.06600 
2017-02-27
2016-12-31-0.010.120.131300 
2016-11-03
2016-09-30-0.11-0.040.0763 
2016-08-03
2016-06-30-0.27-0.160.1140 
2016-05-04
2016-03-31-0.25-0.27-0.02
2016-02-29
2015-12-31-0.22-0.190.0313 
2015-11-10
2015-09-30-0.2-0.22-0.0210 
2015-08-11
2015-06-30-0.21-0.22-0.01
2015-04-30
2015-03-31-0.24-0.180.0625 
2015-02-24
2014-12-31-0.3-0.30.0
2014-11-04
2014-09-30-0.37-0.320.0513 
2014-07-31
2014-06-30-0.39-0.380.01
2014-05-01
2014-03-31-0.37-0.39-0.02
2014-02-20
2013-12-31-0.38-0.380.0
2013-10-30
2013-09-30-0.37-0.360.01
2013-08-06
2013-06-30-0.3-0.34-0.0413 
2013-05-07
2013-03-31-0.28-0.240.0414 
2013-02-21
2012-12-31-0.24-0.28-0.0416 
2012-11-07
2012-09-30-0.3-0.20.133 
2012-08-02
2012-06-30-0.27-0.250.02
2012-05-03
2012-03-31-0.17-0.18-0.01
2012-02-08
2011-12-31-0.110.350.46418 
2011-10-27
2011-09-300.560.590.03
2011-08-04
2011-06-30-0.17-0.160.01
2011-05-03
2011-03-31-0.19-0.24-0.0526 
2011-02-22
2010-12-31-0.2-0.160.0420 
2010-11-04
2010-09-30-0.05-0.08-0.0360 
2010-08-05
2010-06-30-0.21-0.210.0
2010-05-11
2010-03-31-0.31-0.4-0.0929 
2010-03-09
2009-12-31-0.27-0.270.0
2009-10-29
2009-09-30-0.32-0.240.0825 
2009-07-30
2009-06-30-0.41-0.42-0.01
2009-05-07
2009-03-31-0.33-0.34-0.01
2009-03-04
2008-12-31-0.35-0.36-0.01
2008-10-27
2008-09-30-0.41-0.360.0512 
2008-08-05
2008-06-30-0.41-0.43-0.02
2008-05-06
2008-03-31-0.38-0.39-0.01
2008-02-14
2007-12-31-0.29-0.190.134 
2007-11-05
2007-09-30-0.19-0.140.0526 
2007-08-07
2007-06-30-0.28-0.29-0.01
2007-05-03
2007-03-31-0.27-0.250.02
2007-02-13
2006-12-31-0.25-0.27-0.02
2006-11-02
2006-09-30-0.31-0.30.01
2006-08-08
2006-06-30-0.3-0.290.01
2006-05-09
2006-03-31-0.29-0.32-0.0310 
2006-02-21
2005-12-31-0.28-0.29-0.01
2005-11-03
2005-09-30-0.39-0.280.1128 
2005-08-08
2005-06-30-0.05-0.13-0.08160 
2005-05-09
2005-03-31-0.36-0.360.0
2005-02-16
2004-12-31-0.38-0.350.03
2004-11-08
2004-09-30-0.42-0.370.0511 
2004-08-05
2004-06-30-0.38-0.370.01
2004-05-04
2004-03-31-0.41-0.390.02
2004-02-17
2003-12-31-0.35-0.320.03
2003-11-05
2003-09-30-0.38-0.340.0410 
2003-08-06
2003-06-30-0.42-0.40.02
2003-05-07
2003-03-31-0.41-0.380.03
2003-02-19
2002-12-31-0.4-0.340.0615 
2002-11-07
2002-09-30-0.42-0.390.03
2002-08-06
2002-06-30-0.41-0.390.02
2002-05-06
2002-03-31-0.31-0.310.0
2002-03-20
2001-12-31-0.32-0.260.0618 
2001-11-13
2001-09-30-0.31-0.280.03
2001-08-08
2001-06-30-0.31-0.30.01
2001-05-14
2001-03-31-0.26-0.220.0415 
2001-02-28
2000-12-31-0.2-0.180.0210 
2000-11-08
2000-09-30-0.13-0.130.0
2000-08-08
2000-06-30-0.13-0.16-0.0323 

About Exelixis Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Exelixis earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Exelixis estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Exelixis fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-98.6 M-103.6 M
Retained Earnings Total Equity-39.4 M-41.3 M
Earnings Yield 0.05  0.03 
Price Earnings Ratio 18.90  36.74 
Price Earnings To Growth Ratio 0.11  2.62 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in consumer price index.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.725
Earnings Share
2.38
Revenue Per Share
8.288
Quarterly Revenue Growth
0.108
Return On Assets
0.1773
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.